UPDATE: William Blair Starts Lifestance Health Group (LFST) at Outperform

William Blair analyst Ryan Daniels initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Outperform rating.

The analyst comments "We are initiating coverage of LifeStance Health Group, Inc. with an Outperform rating and are establishing the following financial forecasts for the company: for 2021, we project total revenue of $664.4 million, adjusted earnings before interest, taxes, depreciation, and amortization of $66.6 million, and adjusted loss per share of $0.67; for 2022, we project total revenue of $922.8 million, adjusted earnings before interest, taxes, depreciation, and amortization of $100.8 million, and adjusted loss per share of $0.38; and for 2023, we project total revenue of $1,214.1 million, adjusted earnings before interest, taxes, depreciation, and amortization of $168.1 million, and adjusted loss per share of $0.01."

For an analyst ratings summary and ratings history on Lifestance Health Group click here. For more ratings news on Lifestance Health Group click here.

Shares of Lifestance Health Group closed at $27.60 yesterday.

You May Also Be Interested In

• William Blair Downgrades On Holding AG (ONON) to Market Perform
• Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
• Ambiq Micro Inc (AMBQ) PT Raised to $75 at BofA Securities